BIAF — BioAffinity Technologies Balance Sheet
0.000.00%
Last trade - 00:00
HealthcareMicro Cap
- $27.29m
- $25.67m
- $2.53m
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | 0.083 | 1.36 | 11.4 | 2.82 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0.002 | 0.002 | 0.01 | 0.812 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 0.119 | 1.44 | 12 | 3.97 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0.009 | 0.005 | 0.214 | 1.99 |
Net Goodwill | ||||
Other Long Term Assets | ||||
Total Assets | 0.146 | 1.45 | 12.2 | 8.22 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 11.1 | 13 | 1.14 | 2.25 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 11.2 | 13.2 | 1.14 | 3.37 |
Redeemable Preferred Stock | ||||
Non Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | -11 | -11.7 | 11 | 4.86 |
Total Liabilities & Shareholders' Equity | 0.146 | 1.45 | 12.2 | 8.22 |
Total Common Shares Outstanding |